Illumina, Inc.
ILMN Healthcare Diagnostics & Research
Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow ILMN
Illumina, Inc. (ILMN) Shares outstanding
Illumina, Inc.'s shares outstanding at the end of fiscal 2025 was $156.0M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $153.0M. Over the past ten years it has ranged from $148.0M (fiscal 2020) to $159.0M (fiscal 2024); the current reading is higher than 73% of that period. Illumina, Inc. ranks 10th of 52 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $156.0M | (1.89%) |
| FY2024 | $159.0M | 0.63% |
| FY2023 | $158.0M | 0.64% |
| FY2022 | $157.0M | 3.97% |
| FY2021 | $151.0M | 2.03% |
| FY2020 | $148.0M | (0.67%) |
| FY2019 | $149.0M | 0.00% |
| FY2018 | $149.0M | 0.68% |
| FY2017 | $148.0M | 0.00% |
| FY2016 | $148.0M | (0.67%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $153.0M | (0.65%) |
| Mar 2026 | $154.0M | (1.28%) |
| Dec 2025 | $156.0M | 1.30% |
| Sep 2025 | $154.0M | (1.91%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.3M |
| ILMN Illumina, Inc. | $153.0M |
| NTRA Natera, Inc. compare | $143.3M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| WAT Waters Corporation compare | $98.2M |
| LH Labcorp Holdings Inc. compare | $82.0M |
| IDXX IDEXX Laboratories, Inc. compare | $79.3M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on ILMN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement